171 – 179 of 179
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2006
-
Mark
High progesterone receptor expression correlates to the effect of adjuvant tamoxifen in premenopausal breast cancer patients.
(
- Contribution to journal › Article
- 2005
-
Mark
ERK phosphorylation is linked to VEGFR2 expression and Ets-2 phosphorylation in breast cancer and is associated with tamoxifen treatment resistance and small tumours with good prognosis
(
- Contribution to journal › Article
-
Mark
Tumor-specific VEGF-A and VEGFR2 in postmenopausal breast cancer patients with long-term follow-up. Implication of a link between VEGF pathway and tamoxifen response.
(
- Contribution to journal › Article
-
Mark
Cyclin I is expressed in human breast cancer and closely associated with VEGF and KDR expression.
(
- Contribution to journal › Article
- 2004
-
Mark
Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients.
(
- Contribution to journal › Article
-
Mark
Assessment of microvessel density in core needle biopsy specimen in breast cancer
(
- Contribution to journal › Article
-
Mark
Tamoxifen response in primary breast cancer with special reference to tumour-specific VEGF-A and VEGFR2
2004)(
- Thesis › Doctoral thesis (compilation)
- 2003
-
Mark
Decreased angiogenic activity in breast cancer in ever-users of oral contraceptive therapy--preliminary report
(
- Contribution to journal › Article
-
Mark
Lessons from the first patient with an implanted pacemaker: 1958-2001
(
- Contribution to journal › Article